Procalcitonin-guided antibiotic treatment in patients with cancer: a patient-level meta-analysis from randomized controlled trials

Procalcitonin-guided antibiotic treatment in patients with cancer: a patient-level meta-analysis from randomized controlled trials

Abstract Background Use of serum procalcitonin (PCT), an inflammatory biomarker for bacterial infections, has shown promising results for early stopping antibiotic treatment among patients with respiratory infections and sepsis. There is need for additional data regarding effectiveness and safety of...

Full description

Saved in:
Bibliographic Details
Main Authors: Claudia Gregoriano, Yannick Wirz, Ashley Heinsalo, Djilali Annane, Konrad Reinhart, Lila Bouadma, Mirjam Christ-Crain, Kristina B. Kristoffersen, Pierre Damas, Vandack Nobre, Carolina F. Oliveira, Yahya Shehabi, Daiana Stolz, Alessia Verduri, Beat Mueller, Philipp Schuetz
Format: Article
Language:English
Published: BMC 2024-11-01
Series:BMC Cancer
Subjects:
Procalcitonin
Cancer
Antibiotic treatment
Meta-analysis
Online Access:https://doi.org/10.1186/s12885-024-13160-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12885-024-13160-2

Similar Items